81 related articles for article (PubMed ID: 16396966)
1. DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury.
Zheng G; Wang Y; Xiang SH; Tay YC; Wu H; Watson D; Coombes J; Rangan GK; Alexander SI; Harris DC
J Am Soc Nephrol; 2006 Feb; 17(2):465-74. PubMed ID: 16396966
[TBL] [Abstract][Full Text] [Related]
2. CCL2 DNA vaccine to treat renal disease.
Watson D; Zheng G; Wu H; Wang YM; Wang Y; Harris DC; Alexander SI
Int J Biochem Cell Biol; 2009 Apr; 41(4):729-32. PubMed ID: 18768165
[TBL] [Abstract][Full Text] [Related]
3. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
[TBL] [Abstract][Full Text] [Related]
4. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy.
Wu H; Wang Y; Tay YC; Zheng G; Zhang C; Alexander SI; Harris DC
Kidney Int; 2005 Jun; 67(6):2178-86. PubMed ID: 15882261
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines.
Karin N
Isr Med Assoc J; 2000 Jul; 2 Suppl():63-8. PubMed ID: 10909420
[TBL] [Abstract][Full Text] [Related]
7. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of DNA vaccine potency against legumain.
Smahel M; Duskova M; Polakova I; Musil J
J Immunother; 2014 Jun; 37(5):293-303. PubMed ID: 24810641
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene.
Li B; Xiao S; Wang Y; Xu S; Jiang Y; Chen H; Fang L
Vaccine; 2009 Mar; 27(13):1957-63. PubMed ID: 19368777
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
Lee VW; Harris DC
Nephrology (Carlton); 2011 Jan; 16(1):30-8. PubMed ID: 21175974
[TBL] [Abstract][Full Text] [Related]
11. Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy.
Clauss S; Gross O; Kulkarni O; Avila-Ferrufino A; Radomska E; Segerer S; Eulberg D; Klussmann S; Anders HJ
J Pathol; 2009 May; 218(1):40-7. PubMed ID: 19156777
[TBL] [Abstract][Full Text] [Related]
12. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
[TBL] [Abstract][Full Text] [Related]
13. Generation of autoreactive CTL by tumour vaccines containing foreign T helper epitopes.
Steinaa L; Rasmussen PB; Rygaard J; Mouritsen S; Gautam A
Scand J Immunol; 2007 Mar; 65(3):240-8. PubMed ID: 17309778
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
15. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
[TBL] [Abstract][Full Text] [Related]
16. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
[TBL] [Abstract][Full Text] [Related]
17. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
18. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
19. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
20. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]